Ledger.Open graph →
SEC Form D · filed September 23, 2010

Nora Therapeutics, Inc

Offering
$32.6M
Sold
$14.9M
Exemption
Industry
Biotechnology
Location
OWINGS MILLS, MD
Type

People & firms on this filing (18)

Darryl L. Carter · Owing Mills, MDExecDavid E. Schnell · Palo Alto, CADirectorChris Agerton · San Francisco, CAExec · DirectorChen E. Yu · Palo Alto, CADirectorDonald J. Hayden, Jr · Owing Mills, MDDirectorChristopher B. Mcclain · Owing Mills, MDExecBryant E. Fong · San Francisco, CADirectorMartin J. Vogelbaum · New York, NYDirectorAlan Colowick · Palo Alto, CAExec · DirectorRobert Antoniades · Palo Alto, CAExec · DirectorBruce Gittlin · New York, NYExecWilliam H. Reaves · Jersey City, NJExecWilliam A. Ferer · Jersey City, NJDirectorRonald J. Sorenson · Jersey City, NJDirectorTimothy O. Porter · Jersey City, NJDirectorJohn P. Bartlett · Jersey City, NJDirectorMichael Mascis · New York, NYDirectorAlan Colowick · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗